Trial · NCT01253421
Results by group40
Each measurement the trial posted, group by group, in the words and numbers it posted.
21 to 40 of 40
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Effect on Caudate Response to Reward | MDD-amisulpride | 0.5783 | Standard Deviation 1.0104 | Effect size (Beta) | |
| Effect on Caudate Response to Reward | MDD-placebo | -0.2673 | Standard Deviation 0.1575 | Effect size (Beta) | |
| Effect on Caudate Response to Reward | HC-amisulpride | -0.33 | Standard Deviation 1.243 | Effect size (Beta) | |
| Effect on Caudate Response to Reward | HC-placebo | 0.1955 | Standard Deviation 0.1101 | Effect size (Beta) | |
| Effect on NAcc Response to Reward | MDD-amisulpride | 0.9377 | Standard Deviation 0.1357 | Effect size (Beta) | |
| Effect on NAcc Response to Reward | MDD-placebo | 0.1578 | Standard Deviation 0.8534 | Effect size (Beta) | |
| Effect on NAcc Response to Reward | HC-amisulpride | 0.4018 | Standard Deviation 1.2619 | Effect size (Beta) | |
| Effect on NAcc Response to Reward | HC-placebo | 0.954 | Standard Deviation 1.0833 | Effect size (Beta) | |
| Effect on Putamen Response to Reward | MDD-amisulpride | 0.6338 | Standard Deviation 0.8394 | Effect size (Beta) | |
| Effect on Putamen Response to Reward | MDD-placebo | 0.1709 | Standard Deviation 0.7996 | Effect size (Beta) | |
| Effect on Putamen Response to Reward | HC-amisulpride | -0.14 | Standard Deviation 1.2282 | Effect size (Beta) | |
| Effect on Putamen Response to Reward | HC-placebo | 0.436 | Standard Deviation 0.6689 | Effect size (Beta) | |
| Effect on Caudate-dACC Connectivity After Reward | MDD-amisulpride | 0.3628 | Standard Deviation 0.4057 | Effect size (Beta) | |
| Effect on Caudate-dACC Connectivity After Reward | MDD-placebo | 0.3881 | Standard Deviation 0.3415 | Effect size (Beta) | |
| Effect on Caudate-dACC Connectivity After Reward | HC-amisulpride | 0.2992 | Standard Deviation 0.49098 | Effect size (Beta) | |
| Effect on Caudate-dACC Connectivity After Reward | HC-placebo | 0.6192 | Standard Deviation 0.4270 | Effect size (Beta) | |
| Effect on NAcc-MCC Connectivity After Reward | MDD-amisulpride | 0.4375 | Standard Deviation 0.4163 | Effect size (Beta) | |
| Effect on NAcc-MCC Connectivity After Reward | MDD-placebo | 0.324 | Standard Deviation 0.4992 | Effect size (Beta) | |
| Effect on NAcc-MCC Connectivity After Reward | HC-amisulpride | 0.4846 | Standard Deviation 0.6279 | Effect size (Beta) | |
| Effect on NAcc-MCC Connectivity After Reward | HC-placebo | 0.4877 | Standard Deviation 0.5070 | Effect size (Beta) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01253421/results?page=2